212 related articles for article (PubMed ID: 29500868)
1. Cutaneous sarcoidosis in a patient with rheumatoid arthritis receiving tocilizumab.
Shono Y; Kamata M; Takeoka S; Ikawa T; Tateishi M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Asako K; Kono H; Tada Y
J Dermatol; 2018 Aug; 45(8):e217-e218. PubMed ID: 29500868
[No Abstract] [Full Text] [Related]
2. Sarcoidosis induced by tocilizumab: a paradoxical event?
Nutz A; Pernet C; Combe B; Cohen JD
J Rheumatol; 2013 Oct; 40(10):1773-4. PubMed ID: 24085760
[No Abstract] [Full Text] [Related]
3. Sarcoidosis and tocilizumab: is there a link?
Bustamente L; Buscot M; Marquette CH; Roux C
Clin Exp Rheumatol; 2017; 35(4):716. PubMed ID: 28516883
[No Abstract] [Full Text] [Related]
4. Toxidermia under treatment with tocilizumab for rheumatoid arthritis.
Fechtenbaum M; Banse C; Boyard-Lasselin P; Goëb V
Joint Bone Spine; 2015 Jan; 82(1):69-70. PubMed ID: 25048098
[No Abstract] [Full Text] [Related]
5. Tocilizumab-induced leucocytoclastic vasculitis in a patient with rheumatoid arthritis.
Sakaue S; Sumitomo S; Kubo K; Fujio K; Yamamoto K
Rheumatology (Oxford); 2014 Aug; 53(8):1529-30. PubMed ID: 24609062
[No Abstract] [Full Text] [Related]
6. Tumor necrosis factor-α inhibitor-induced antiglomerular basement membrane antibody disease in a patient with rheumatoid arthritis.
Nishimura K; Saegusa J; Kawano S; Morinobu A
J Rheumatol; 2012 Sep; 39(9):1904-5. PubMed ID: 22942311
[No Abstract] [Full Text] [Related]
7. CD30-positive Cutaneous Pseudolymphoma Caused by Tocilizumab in a Patient with Rheumatoid Arthritis: Case Report and Literature Review.
Inoue A; Sawada Y; Ohmori S; Omoto D; Haruyama S; Yoshioka M; Nishio D; Nakamura M
Acta Derm Venereol; 2016 May; 96(4):570-1. PubMed ID: 26631390
[No Abstract] [Full Text] [Related]
8. IL-6 inhibition for the treatment of rheumatoid arthritis and other conditions.
Woodrick RS; Ruderman EM
Bull NYU Hosp Jt Dis; 2012; 70(3):195-9. PubMed ID: 23259628
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor-associated palmoplantar pustular psoriasis treated with interleukin 6 blocker.
Younis S; Rimar D; Slobodin G; Rosner I
J Rheumatol; 2012 Oct; 39(10):2055-6. PubMed ID: 23028035
[No Abstract] [Full Text] [Related]
10. [Sarcoidosis after adalimumab treatment in inflammatory rheumatic diseases: a report of two cases and literature review].
Scailteux LM; Guedes C; Polard E; Perdriger A
Presse Med; 2015 Jan; 44(1):4-10. PubMed ID: 25534463
[TBL] [Abstract][Full Text] [Related]
11. Cerebral toxoplasmosis following adalimumab treatment in rheumatoid arthritis.
Nardone R; Zuccoli G; Brigo F; Trinka E; Golaszewski S
Rheumatology (Oxford); 2014 Feb; 53(2):284. PubMed ID: 24191065
[No Abstract] [Full Text] [Related]
12. Hypersensitivity reactions to tocilizumab: role of skin tests in diagnosis.
Rocchi V; Puxeddu I; Cataldo G; Del Corso I; Tavoni A; Bazzichi L; Bombardieri S; Migliorini P
Rheumatology (Oxford); 2014 Aug; 53(8):1527-9. PubMed ID: 24899663
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of tocilizumab combined with cyclosporine A in a patient with rheumatoid arthritis and concomitant chronic hepatitis C virus infection.
Giannitti C; Fineschi I; Frediani B; Fioravanti A; Galeazzi M
Clin Exp Rheumatol; 2013; 31(5):816. PubMed ID: 24021246
[No Abstract] [Full Text] [Related]
14. Onset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect?
Wendling D; Dernis E; Prati C; Frisch E; Delbosc B
J Rheumatol; 2011 Oct; 38(10):2284. PubMed ID: 21965707
[No Abstract] [Full Text] [Related]
15. [Clinical effect of tocilizumab on patients with severe active rheumatoid arthritis].
Xu S; Xie X; Tang M; Chen J; Tian J; Du J; Mao N; Liu Y; Li S; Song M; Gao J; Ling G; Li F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Oct; 42(10):1174-1177. PubMed ID: 29093249
[TBL] [Abstract][Full Text] [Related]
16. Sarilumab (Kevzara) for rheumatoid arthritis.
Med Lett Drugs Ther; 2017 Aug; 59(1527):134-136. PubMed ID: 28787744
[No Abstract] [Full Text] [Related]
17. Synovial fluid IL-6 concentrations associated with positive response to tocilizumab in an RA patient with failed response to anti-TNF and rituximab.
Wright HL; Mewar D; Bucknall RC; Edwards SW; Moots RJ
Rheumatology (Oxford); 2015 Apr; 54(4):743-4. PubMed ID: 25667432
[No Abstract] [Full Text] [Related]
18. Recurrent allergic bronchopulmonary aspergillosis in a patient with rheumatoid arthritis treated with etanercept and tocilizumab.
Honda H; Kida H; Yoshida M; Tomita T; Fujii M; Ihara S; Goya S; Tachibana I; Kawase I
Mod Rheumatol; 2011 Dec; 21(6):660-4. PubMed ID: 21472474
[TBL] [Abstract][Full Text] [Related]
19. Sarcoidosis during anti-tumor necrosis factor-alpha therapy: no relapse after rechallenge.
van der Stoep D; Braunstahl GJ; van Zeben J; Wouters J
J Rheumatol; 2009 Dec; 36(12):2847-8. PubMed ID: 19966199
[No Abstract] [Full Text] [Related]
20. Treatment of Rheumatoid Arthritis With Anti-Tumor Necrosis Factor or Tocilizumab Therapy as First Biologic Agent in a Global Comparative Observational Study.
Choy EH; Bernasconi C; Aassi M; Molina JF; Epis OM
Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1484-1494. PubMed ID: 28622454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
